Beyond Compliance: The Ethical and Business Demands for Clinical Trial Transparency, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will illustrate how clinical trial sponsors can give their data superpowers and be seen as transparency leaders in the industry. Attendees will learn about the advantages of repurposing trial data, the post-COVID implications of data sharing and transparency’s impact on brand reputation.

By repurposing clinical trial information instead of letting it languish in a database, sponsors can turn “patient engagement” from a buzzword to an actionable business practice.

When we think of transparency in the pharmaceutical industry, our thoughts often focus on transparency in drug pricing. However, regulatory and corporate obligations also call for disclosure of clinical trial information. Public opinion of the pharmaceutical industry has plummeted in recent years. Today, the coronavirus pandemic has placed pharmaceutical companies under a global microscope. Industry watchdogs, patient advocacy organizations and the public in general are demanding greater transparency. This provides clinical trial sponsors the opportunity to make transparency a priority and improve the reputation of their brands and the industry as a whole.

Clinical trials produce a wealth of data, much of which can be repurposed to the sponsor’s advantage. For example, this data can be synced to the search engine of a clinical trial finder website, can help better match patients to clinical trials, and can be shared with other researchers upon request. By repurposing clinical trial information instead of letting it languish in a database, sponsors can turn “patient engagement” from a buzzword to an actionable business practice.

The COVID-19 pandemic brings to light the ethics of getting information out more quickly than strictly required by regulation, or more thoroughly, as medical professionals, media and the general public are all looking for effective and safe treatments. The pandemic also has shown that collaboration is possible within the pharmaceutical community. Drug makers are partnering with one another, as well as with academic institutions, uniting to develop a vaccine.

Join Thomas Wicks, Chief Strategy Officer, TrialScope and Francine Lane, Vice President of Global Transparency, TrialScope in a live webinar on Friday, October 23, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Beyond Compliance: The Ethical and Business Demands for Clinical Trial Transparency.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website